Search Results - "Lunell, Erik"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    Pharmacokinetic Comparison of a Novel Non-tobacco-Based Nicotine Pouch (ZYN) With Conventional, Tobacco-Based Swedish Snus and American Moist Snuff by Lunell, Erik, Fagerström, Karl, Hughes, John, Pendrill, Robert

    Published in Nicotine & tobacco research (08-10-2020)
    “…The single-dose pharmacokinetics (PK) of a novel, non-tobacco-based nicotine pouch, ZYN, 3 and 6 mg, were compared with 8 mg General snus (part 1) and ZYN 8 mg…”
    Get full text
    Journal Article
  2. 2

    Exposure to high ambient temperature increases absorption and plasma concentrations of transdermal nicotine by Vanakoski, J, Seppälä, T, Sievi, E, Lunell, E

    Published in Clinical pharmacology and therapeutics (01-09-1996)
    “…Absorption and plasma concentrations of transdermally delivered drugs may be increased during heat exposure. We studied the effects of short-term heat exposure…”
    Get more information
    Journal Article
  3. 3

    Nicotine Delivery and Subjective Effects of Swedish Portion Snus Compared With 4 mg Nicotine Polacrilex Chewing Gum by Lunell, Erik, Curvall, Margareta

    Published in Nicotine & tobacco research (01-07-2011)
    “…Introduction: Snus availability has been claimed to have contributed to the low rates of smoking among Swedish men and made possible the transfer to a less…”
    Get full text
    Journal Article
  4. 4

    Steady-state nicotine plasma levels following use of four different types of Swedish snus compared with 2-mg Nicorette chewing gum: A crossover study by Lunell, Erik, Lunell, Marianne

    Published in Nicotine & tobacco research (01-06-2005)
    “…The present study evaluated nicotine plasma levels achieved following 1 day's regular use of four commonly used brands of Swedish portion snus and 2-mg…”
    Get full text
    Journal Article
  5. 5

    Pharmacokinetics of nicotine in healthy elderly people by Molander, Lars, Hansson, Anna, Lunell, Erik

    Published in Clinical pharmacology and therapeutics (01-01-2001)
    “…Background Mortality hazards of smoking extend well into later life; this suggests that smoking cessation will continue to improve life expectancy in older…”
    Get full text
    Journal Article
  6. 6

    The nicotine inhaler: Clinical pharmacokinetics and comparison with other nicotine treatments by SCHNEIDER, Nina G, OLMSTEAD, Richard E, FRANZON, Mikael A, LUNELL, Erik

    Published in Clinical pharmacokinetics (2001)
    “…Nicotine inhaled in smoke is the most rapid form of delivery of the drug. With smoking, arterial boli and high venous blood nicotine concentrations are…”
    Get full text
    Journal Article
  7. 7

    Aiding reduction of smoking with nicotine replacement medications: hope for the recalcitrant smoker? by Fagerström, K O, Tejding, R, Westin, A, Lunell, E

    Published in Tobacco control (1997)
    “…OBJECTIVE: To assess the effect of the various nicotine replacement therapies (NRT) on smoking reduction. DESIGN: During an initial sampling week, the subjects…”
    Get full text
    Journal Article
  8. 8

    Enprofylline kinetics in healthy subjects after single doses by Borgå, O, Andersson, K E, Edholm, L E, Fagerström, P O, Lunell, E, Persson, C G

    Published in Clinical pharmacology and therapeutics (01-12-1983)
    “…The kinetics of enprofylline, a novel antiasthmatic xanthine derivative, were studied. Eight healthy subjects received three different single enprofylline…”
    Get more information
    Journal Article
  9. 9

    Pharmacokinetics of nicotine in kidney failure by Molander, Lars, Hansson, Anna, Lunell, Erik, Alainentalo, Lisbeth, Hoffmann, Mikael, Larsson, Rutger

    Published in Clinical pharmacology and therapeutics (01-09-2000)
    “…Background Smoking is an important risk factor for cardiovascular and cerebrovascular complications in patients with chronic kidney failure. Very high plasma…”
    Get full text
    Journal Article
  10. 10

    Electroencephalographic effects of intravenous nicotine : a dose-response study by LINDGREN, M, MOLANDER, L, VERBAAN, C, LUNELL, E, ROSEN, I

    Published in Psychopharmacologia (01-08-1999)
    “…It has often been demonstrated that both tobacco abstinence and nicotine have effects on the EEG power spectrum and components of the event-related potentials…”
    Get full text
    Journal Article
  11. 11

    Clinical pharmacokinetics of nasal nicotine delivery : A review and comparison to other nicotine systems by SCHNEIDER, N. G, LUNELL, E, OLMSTEAD, R. E, FAGERSTRÖM, K.-O

    Published in Clinical pharmacokinetics (01-07-1996)
    “…Rapid drug delivery (arterial "boli') and high drug concentrations occur with nicotine inhaled in smoke. These are believed to be key elements in producing…”
    Get full text
    Journal Article
  12. 12

    Reduction of tobacco withdrawal symptoms with a sublingual nicotine tablet: a placebo controlled study by Molander, Lars, Lunell, Erik, Fagerström, Karl Olov

    Published in Nicotine & tobacco research (01-05-2000)
    “…Many smokers are unable to use gum as a cessation aid due to fillings, bridgework and dyspepsia or they reject it for esthetic reasons. The nicotine sublingual…”
    Get full text
    Journal Article Conference Proceeding
  13. 13
  14. 14

    Dose released and absolute bioavailability of nicotine from a nicotine vapor inhaler by Molander, L, Lunell, E, Andersson, S B, Kuylenstierna, F

    Published in Clinical pharmacology and therapeutics (01-04-1996)
    “…In an open, randomized, three-way crossover study, 14 healthy smokers used one type of nicotine vapor inhaler intensely for 20 minutes every hour for 11 hours…”
    Get more information
    Journal Article
  15. 15

    Biological availability and pharmacokinetics of tinidazole after single and repeated doses by Vinge, E, Andersson, K E, Ando, G, Lunell, E

    “…Tinidazole was administered to healthy volunteers and serum concentrations were measured following single oral and intravenous doses and after repeated dosage…”
    Get more information
    Journal Article
  16. 16

    Acute Effects of Nicotine Infusion on Platelets in Nicotine Users with Normal and Impaired Renal Function by Whiss, Per A., Lundahl, Tom H., Bengtsson, Torbjörn, Lindahl, Tomas L., Lunell, Erik, Larsson, Rutger

    Published in Toxicology and applied pharmacology (01-03-2000)
    “…The role of platelets in cardiovascular disease associated with smoking is becoming more established, but the effects of nicotine on platelets are unclear…”
    Get full text
    Journal Article
  17. 17

    Regional deposition of inhaled 11C-nicotine vapor in the human airway as visualized by positron emission tomography by Bergström, M, Nordberg, A, Lunell, E, Antoni, G, Långström, B

    Published in Clinical pharmacology and therapeutics (01-03-1995)
    “…The deposition of 11C-nicotine in the respiratory tract from a nicotine vapor inhaler was studied by means of positron emission tomography (PET) in an…”
    Get more information
    Journal Article